TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Share Price
Certificat
DE000SN0N1Z9
| Delayed Deutsche Boerse AG 12:11:23 24/06/2024 BST | ||
| 1.78 EUR | -1.66% |
|
| Current month | +9.04% | ||
| 1 month | +18.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24/06/24 | 1.78 | -1.66% |
| 21/06/24 | 1.81 | 0.00% |
| 20/06/24 | 1.81 | +4.02% |
| 19/06/24 | 1.74 | -2.25% |
| 18/06/24 | 1.78 | -3.78% |
Delayed Quote Deutsche Boerse AG
Last update June 24, 2024 at 12:11 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SN0N1Z |
| ISIN | DE000SN0N1Z9 |
| Date issued | 09/05/2022 |
| Strike | 279 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.93 € |
|---|---|
| Lowest since issue | 0.05 € |
| Spread | 0.03 € |
| Spread % | 1.66% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
468.7
USD
Average target price
463.4
USD
Spread / Average Target
-1.13%
- Stock Market
- Certificates
- Certificat
